Crude oil futures have flipped higher amid ongoing geopolitical tensions between the U.S. and Iran, with fears of prolonged conflict supporting prices despite early session weakness. The disruption of oil flows through the Strait of Hormuz has removed millions of barrels from the market, tightening global supply and pressuring inventories lower. Traders remain cautious, pricing oil based on the potential duration of the conflict rather than temporary diplomatic developments. Technically, oil prices are in an uptrend, with key support and resistance levels indicating strength, while the supply cushion is shrinking faster than expected, suggesting further price increases if disruptions continue. Iran faces a critical decision soon, with the possibility of U.S. military action looming, keeping oil markets on edge.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Thor Explorations produced 19,153 ounces of gold in Q2 2026 from its Segilola mine in Nigeria, maintaining its full-year production guidance of 75,000 to 85,000 ounces. The company generated $77.3 million in revenue by selling 17,050 ounces at an ave...
Angelini Pharma has finalized its $4.1 billion acquisition of Catalyst Pharmaceuticals, enhancing its footprint in the U.S. market and strengthening its global leadership in brain health and rare diseases. The deal includes significant investments fr...
Zcash (ZEC) has gained over 16% in the past week, rallying from lows near $368 to around $552 following an 11% jump in one session. This surge is driven by anticipation of the Ironwood shielded pool upgrade expected around July 28, which addresses a ...
Greenwich LifeSciences is developing GLSI-100, an immunotherapy targeting HER2-positive breast cancer, currently in Phase 3 trials. The drug showed a 70-80% reduction in cancer recurrence in Phase 2b, outperforming existing treatments with no serious...
